Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer
- PMID: 12559074
- DOI: 10.1053/ejso.2002.1391
Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer
Abstract
Aims: Infiltrating Lobular Carcinoma (ILC) accounts for 5-10% of all breast cancers and is associated with subtle clinical and mammographic changes. It is also frequently multifocal and traditional diagnostic methods are unable to reliably detect this preoperatively. The aim of the study was to evaluate the efficacy of current imaging modalities compared with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in the evaluation of ILC.
Methods: Data from women with ILC treated between 1996 and 2000 who had undergone preoperative triple assessment and DCE-MRI was analysed. The diagnostic accuracy and the detection of multifocal disease for each modality was assessed and any changes in clinical management following DCE-MRI were recorded.
Results: Twenty-one women (mean age 57, range 43-72 years) were recruited. The sensitivity of X-ray mammography, ultrasound, clinical assessment, fine needle aspiration cytology or core biopsy and DCE-MRI was 90.5, 87.5, 76.2, 85.7 and 95.2% respectively. DCE-MRI identified all the patients with subsequently histologically proven multifocal disease (n=11) with PPV and NPV of 100 and 95.2% respectively. X-ray mammography and ultrasound combined identified only 27% (n=3/11) with PPV and NPV of 100 and 55.6% respectively. Management was changed in 24% (5/21) of the cases following DCE-MRI.
Conclusion: DCE-MRI has a higher sensitivity than other imaging modalities and is able to accurately delineate multifocal disease not evident on conventional imaging. DCE-MRI should therefore be used for accurate staging prior to surgery for invasive lobular breast cancer.
Similar articles
-
Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer.Ann Surg Oncol. 1999 Sep;6(6):599-603. doi: 10.1007/s10434-999-0599-x. Ann Surg Oncol. 1999. PMID: 10493630
-
[Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma].Rofo. 2004 Apr;176(4):544-9. doi: 10.1055/s-2004-813011. Rofo. 2004. PMID: 15088179 German.
-
Contrast-enhanced MR imaging of breast lesions and effect on treatment.Eur J Surg Oncol. 2004 Jun;30(5):501-7. doi: 10.1016/j.ejso.2004.02.003. Eur J Surg Oncol. 2004. PMID: 15135477
-
Mammography, sonography and MRI for detection and characterization of invasive lobular carcinoma of the breast.Breast Dis. 2008-2009;30:21-30. doi: 10.3233/BD-2009-0279. Breast Dis. 2008. PMID: 19850992 Review.
-
Invasive Lobular Carcinoma in the Screening Setting.J Breast Imaging. 2025 Jan 25;7(1):3-15. doi: 10.1093/jbi/wbae082. J Breast Imaging. 2025. PMID: 39657621 Review.
Cited by
-
MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature.Breast Cancer Res Treat. 2008 Jan;107(1):1-14. doi: 10.1007/s10549-007-9528-5. Epub 2007 Feb 15. Breast Cancer Res Treat. 2008. PMID: 18043894 Free PMC article. Review.
-
Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer?Eur Radiol. 2016 May;26(5):1457-65. doi: 10.1007/s00330-015-3935-5. Epub 2015 Aug 14. Eur Radiol. 2016. PMID: 26268905
-
Biomarkers in Breast Cancer: An Old Story with a New End.Genes (Basel). 2023 Jun 28;14(7):1364. doi: 10.3390/genes14071364. Genes (Basel). 2023. PMID: 37510269 Free PMC article. Review.
-
Whole Breast Invasive Lobular Carcinoma Not Detected Radiographically.Cureus. 2020 Sep 14;12(9):e10438. doi: 10.7759/cureus.10438. Cureus. 2020. PMID: 33072448 Free PMC article.
-
Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).Radiol Med. 2019 Dec;124(12):1229-1237. doi: 10.1007/s11547-019-01116-7. Epub 2019 Nov 26. Radiol Med. 2019. PMID: 31773458
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical